£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study examines the latent demand outlook for uterine sarcoma therapeutics and diagnostics across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions, and Taiwan. The analysis covers potential industry earnings estimates across approximately 1,100 cities throughout China, providing detailed market penetration data and regional demand projections. Researchers and healthcare professionals gain actionable insights into growth opportunities, market dynamics, and investment potential within China's oncology sector over the five-year forecast period.

Key Features

Covers all Chinese regions including provinces, autonomous regions, municipalities, Hong Kong, Macau, and Taiwan for comprehensive market analysis.

Provides latent demand estimates in millions of U.S. dollars across approximately 1,100 cities in China.

Delivers potential industry earnings forecasts to identify high-value market opportunities for uterine sarcoma treatments.

Includes regional market share percentages by city to benchmark performance and prioritise market entry strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
92% match

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

£495.00 28 Sep 2026
The 2023-2028 World Outlook for Endometrial Cancer Treatments
90% match

The 2023-2028 World Outlook for Endometrial Cancer Treatments

£795.00 15 Sep 2026
2023-2028 Compact Advance Radiotherapy Systems Outlook - China
90% match

2023-2028 Compact Advance Radiotherapy Systems Outlook - China

£495.00 28 Sep 2026
2023-2028 Injectable Drug Delivery Devices Outlook China
89% match

2023-2028 Injectable Drug Delivery Devices Outlook China

£495.00 28 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
89% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
89% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
88% match

China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook

£495.00 28 Sep 2026
2023-2028 Proteomics Outlook for China - Market Analysis
88% match

2023-2028 Proteomics Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
88% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
87% match

2023-2028 Nasal Drug Delivery Outlook for China - Market Research

£495.00 28 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
87% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
87% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States

£520.00 27 Sep 2026
2023-2028 Viral Clearance Services Outlook China
87% match

2023-2028 Viral Clearance Services Outlook China

£495.00 28 Sep 2026
2023-2028 HPV Vaccines Outlook for China - Market Analysis
87% match

2023-2028 HPV Vaccines Outlook for China - Market Analysis

£495.00 29 Sep 2026
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
87% match

The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India

£515.00 27 Sep 2026
2023-2028 Feminine Hygiene Products Outlook - China Market Report
87% match

2023-2028 Feminine Hygiene Products Outlook - China Market Report

£495.00 28 Sep 2026
2023-2028 Home Health Care Services Outlook for China
87% match

2023-2028 Home Health Care Services Outlook for China

£495.00 28 Sep 2026
2023-2028 Mycotoxin Binders Outlook for China - Market Analysis
87% match

2023-2028 Mycotoxin Binders Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
87% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
2023-2028 Breast Implants Market Outlook for China
87% match

2023-2028 Breast Implants Market Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Colorectal Cancers for US Zip Codes
87% match

The 2023-2028 Outlook for Colorectal Cancers for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India
87% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Rheumatology Therapeutics in India
87% match

The 2023-2028 Outlook for Rheumatology Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Malignant Melanoma Treatments in India
87% match

The 2023-2028 Outlook for Malignant Melanoma Treatments in India

£515.00 27 Sep 2026